You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金域醫學(603882.SH)持續創新高 年內累漲153%
格隆匯 09-19 13:34
近日不斷創出歷史新高價的金域醫學(603882.SH)漲勢繼續,現報56.36元,漲5.33%,暫成交2.09億元,最新總市值259億元。該股盤中再創歷史新高價56.56元,年內已累漲153%。 金域醫學是一家專業從事第三方醫學檢驗及病理診斷業務的獨立醫學實驗室。據悉,國內第三方醫學實驗室行業中僅有金域醫學和迪安診斷完成了全國的網絡佈局。而從當前第三方醫學實驗室行業的市場份額上看,金域醫學遙遙領先,實驗室數有37家,客户數覆蓋2.2萬餘家,檢查項目數2600餘項,檢測標本量年檢測標本量超6000萬例,業務領域覆蓋常規生化免疫檢驗、病理檢驗、基因組學檢驗等。有機構分析指出,金域醫學有望成為中國版的第三方醫學實驗室巨頭。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account